Cofilin-2 (rs80358250) and Lactoferrin (rs1126478) Polymorphism and Protein Levels With Non Surgical Periodontal Therapy in Periodontitis Patients With and Without CHD
NCT07353606 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84
Last updated 2026-01-22
Summary
Periodontitis is a chronic multifactorial inflammatory disease associated with the accumulation of dental plaque and characterized by progressive destruction of the teeth-supporting apparatus, including the periodontal ligament and alveolar bone. Dental plaque accumulation at the gingival margin initiates an inflammatory response that, in turn, causes microbial alterations and may lead to drastic consequences in the periodontium of susceptible individuals. The pathophysiology of periodontitis is influenced by the relationship between the host immune system and periodontal pathogens. The presence of periodontal pathogens and their metabolic by-products in the oral cavity may get disseminated to the systemic circulation which may pose a risk for various systemic diseases such as cardiovascular disease, oral and colorectal cancer, gastrointestinal diseases, respiratory tract infection, adverse pregnancy outcomes and diabetes.
Although pathogenic bacteria and various other environmental factors are involved in pathogenesis of periodontitis, genetic factors are also known to play a pivotal role in influencing the inflammatory and immune response. Genetic polymorphisms are alterations in the DNA sequence found in general population. Most forms of periodontitis represent a life-long account of interactions between the genome and the environment. The previous literature has stated a strong association of genetic polymorphisms in periodontitis and coronary artery diseases. Identifying these polymorphisms can potentially lead to a better understanding of the mechanisms modulating the expression of inflammatory mediators as well as provides potential therapeutic targets in the prevention of periodontal disease. Two such novel polymorphisms have gained attention recently, namely the Cofilin-2 and Lactoferrin polymorphisms.
Cofilin is one of the most affluent and common actin-binding proteins and plays a role in cell motility, migration, shape, and metabolism. They also play an important role in severing actin filament, nucleating, depolymerizing and bundling activities. Cofilin is the major ADF/cofilin isoform in mammalian neurons influences the dynamics of actin assembly by severing or stabilizing actin filaments. Cofilin-2 is the only isoform present in mature skeletal muscles. It is composed of 5 α helices, 5 β sheets, and 1 C-terminal β short chain, with a molecular weight of 18 kDa. Cofilin-2 is a member of the AC group of proteins that also includes cofilin-1 and destrin, all of which regulate actin-filament dynamics. Recently, Cofilin 2 gained attention as an emerging biomarker for coronary heart diseases. Cofilin-2 has shown to play a role in pathophysiology of coronary heart disease.
Lactoferrin is a multifunctional protein of the transferrin family. Lactoferrin is a globular glycoprotein with a molecular mass of about 80 kDa that is widely represented in various secretory fluids, such as milk, saliva, tears and nasal secretions. Lactoferrin, a multifunctional iron-binding glycoprotein, is involved in coronary heart disease pathophysiology. Recent studies reported that Lactoferrin polymorphism is associated with an increased risk of coronary artery disease in the elderly population.
Studies have been done to identify Lactoferrin genetic polymorphisms, however none of the studies have explored the role of Lactoferrin (rs1126478) and its protein level in subjects with both periodontal disease and coronary heart disease occurring as a continuum. Its expression in periodontitis and coronary heart disease patients is yet to be explored. Genetic polymorphism and protein levels of Cofilin-2 (rs80358250) has been never studied in coronary heart disease and periodontitis. This may further improve our understanding of the influence of this polymorphism on the above mentioned systemic diseases.
NEED FOR THE STUDY While there are studies which have demonstrated the expression of Cofilin-2 and Lactoferrin polymorphisms in various inflammatory conditions, there are no studies to state their expression in the subgingival plaque samples of periodontitis patients with coronary artery disease, specifically before and after non-surgical therapy. Also, the correlation of both these polymorphisms and their levels with periodontal and cardiac parameters has never been investigated so far. It is suggested that these polymorphisms may play a role as putative risk indicators in periodontitis subjects with coronary heart disease which may alter following non-surgical periodontal therapy.
Conditions
- Periodontitis
- Chronic Periodontitis (Disorder)
- Coronary Heart Disease
Interventions
- PROCEDURE
-
Scaling and root planing
Scaling and root planing is a deep cleaning below the gumline used to treat gum disease. Gum disease is caused by a sticky film of bacteria called plaque. Plaque is always forming on your teeth, but if they aren't cleaned well, the bacteria in plaque can cause your gums to become inflammed.
Sponsors & Collaborators
-
Meenakshi Ammal Dental College and Hospital
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 30 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-11-20
- Primary Completion
- 2026-04-20
- Completion
- 2026-04-20
Countries
- India
Study Locations
More Related Trials
-
Influence of Periodontal Disease Treatment on Serum Levels of Sirtuin 1 and Mannose-binding Lectin
NCT03753451 ·Status: COMPLETED ·Phase: NA
-
Effect of Scaling and Root Planing on Serum Renal Function Markers in Chronic Periodontitis Subjects.
NCT02636114 ·Status: COMPLETED ·Phase: NA
-
Role of Leukotriene Receptor Antagonists in Treatment of Chronic Periodontitis
NCT02014532 ·Status: COMPLETED ·Phase: PHASE4
-
Serum TRAP-5b Levels in Patients With Generalized Chronic Periodontitis
NCT03043066 ·Status: COMPLETED ·Phase: NA
-
Quantification of NLRP3 (rs4612666) and CARD8 Gene (rs2043211) in Generalized Chronic Periodontitis Subjects
NCT04127487 ·Status: UNKNOWN
-
Gingival Crevicular Fluid Levels of Protein Carbonyl Following the Use of Lycopene in Chronic Periodontitis
NCT03203746 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treatment of Periodontal Disease in Patients With Acute Myocardial Infarction
NCT02543502 ·Status: COMPLETED ·Phase: NA
-
Interplay of miRNA-146a and miRNA-126 in Chronic Periodontitis Patients With Coronary Artery Disease
NCT04583085 ·Status: COMPLETED
-
Effects of i-PRF on Non-surgical Periodontal Treatment
NCT05753631 ·Status: COMPLETED
-
Non-invasive Assessment of Inflammatory Markers MIP-1 Alpha and IL-6 in Saliva of Post Myocardial Infarction and Stage 4 Periodontitis Patients
NCT05314192 ·Status: COMPLETED
-
Role of Herbal Immunomodulators in the Treatment of Chronic Periodontitis
NCT01997814 ·Status: COMPLETED ·Phase: PHASE4
-
Serum Lipid Levels and Lp-PLA2 in Chronic Periodontitis
NCT03041480 ·Status: COMPLETED
-
Injectable Platelet Rich Fibrin With Non Surgical Periodontal Therapy
NCT04070729 ·Status: UNKNOWN ·Phase: NA
-
NSPT on Calprotectin and Periostin Levels
NCT05618743 ·Status: UNKNOWN ·Phase: NA
-
Galectin Role in Periodontal Disease
NCT06038812 ·Status: COMPLETED ·Phase: NA
-
The Effect of Locally Dilvered Ciprofloxacine Loaded Injectable Platelet-rich Fibrin as an Adjunct to Non-surgical Periodontal Therapy on the Gingival Crevicular Level of Interleukin 6
NCT06968286 ·Status: COMPLETED ·Phase: NA
-
i-PRF & Root Surface Biomodification
NCT07207668 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Injectable Platelet-rich Fibrin Versus Platelet-Rich Plasma As Adjunctive to Scaling and Root Planning in Non-surgical Periodontal Therapy of Periodontitis Patients
NCT06685393 ·Status: COMPLETED ·Phase: NA
-
Effect of Tooth Cleaning in Smokers and Non Smokers With Gum Disease.
NCT02930356 ·Status: COMPLETED ·Phase: NA
-
Impact of Non-surgical Periodontal Therapy on Oral and Gut Microbiome
NCT04580355 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Non-surgical Periodontal Therapy on the Gingival Crevicular Fluid Levels of Prolactin Hormone in Patients With Periodontitis.
NCT03726411 ·Status: COMPLETED ·Phase: NA
-
Quantification of CD163 Inflammatory Biomarker in Chronic Periodontitis and Diabetic Subjects
NCT03727035 ·Status: UNKNOWN
-
Platelet-rich Fibrin With 1.2% Rosuvastatin in Chronic Periodontitis Treatment
NCT02645227 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of Inflammatory Markers and Periodontal Viruses on Periodontitis Patients With CAD
NCT04172870 ·Status: UNKNOWN
-
Effects of Probiotic Therapy in the Treatment of Periodontitis.
NCT03408548 ·Status: COMPLETED ·Phase: PHASE2